Healthcare

AN2 Therapeutics scores $12 mln Series A

California-based AN2 Therapeutics Inc, a biopharmaceutical company focused on infectious diseases, has raised $12 million in Series A financing. Mountain Group Partners led the round with participation from Adjuvant Capital, Brii Biosciences and BioRock Ventures.

KKR to make 3x its money on sale of LGC

The deal assigns LGC a value of approximately 3 billion pounds ($3.9 billion)

Lincoln International recruits Siano as MD

Michael Siano has jointed Lincoln International from Houlihan Lokey and will lead coverage of the Healthcare Information Technology sector.

Genesis Therapeutics takes in $4.1 mln seed

South San Francisco-based Genesis Therapeutics, a biotech company, has raised $4.1 million in seed funding. Andreessen Horowitz led the round with participation from Felicis Ventures.

Advent sticks to BAU while others worry about 'Medicare for All'

Some dealmakers are worried about “Medicare for All” legislation proposed by presidential candidates Bernie Sanders and Elizabeth Warren.

ArchiMed adds three new partners

Christophe Berthoux, Jean-Yves Desmottes and Mario Philips have been hired as partners at the independent healthcare investment firm.

Advent sees opportunity in healthcare payments, corporate carveouts

Managing partner John Maldonado shares his insight into the firm's healthcare investment strategy.

KKR to sell LGC to Cinven and Astorg

KKR said Nov. 21 that it agreed to sell LGC to Cinven and Astorg. Financial terms weren’t announced. LGC provides life science tools to customers in end markets, including human healthcare, agri-food & the environment.

GPs navigate high prices through relationships, buy-and-build strategies

Phoenix Molecular secures seed funding

Vancouver, British Columbia and San Diego-based Phoenix Molecular, a developer of precise cancer therapeutics targeting essential kinases, has raised US$12 million in seed funding. The investors included Pallasite Ventures and World Changing Ventures.